<DOC>
	<DOCNO>NCT01549496</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic interaction hepatitis C NS3 protease inhibitor boceprevir calcium channel blocker amlodipine diltiazem healthy volunteer .</brief_summary>
	<brief_title>A Drug Interaction Study Boceprevir Combination With Amlodipine Diltiazem Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>1 . Able willing sign inform consent prior studyrelated activity . 2 . Male female subject 18 65 year age inclusive . 3 . Healthy , i.e . suffer relevant acute chronic illness . 4 . Body Mass Index ( BMI ) 17.5 31 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . 5 . Acceptable medical history , physical examination , 12lead ECG screening . 6 . Acceptable laboratory value indicate adequate baseline organ function screen visit . 7 . Willing stop use herbal natural health product 2 week prior study include : Grapefruit , grapefruit juice , St. John 's Wort . 8 . Willingness abstain alcohol use 3 day prior study . 9 . Female subject either childbearing potential , defined postmenopausal least 1 year surgically sterile ( bilateral tubal ligation , bilateral oophorectomy hysterectomy ) , childbearing potential practice one follow method birth control : Condoms , sponge , foam , jelly , diaphragm intrauterine device ( IUD ) A vasectomized partner Total abstinence sexual intercourse 1 . Have serological evidence exposure HIV HCV . 2 . Known allergy study medication . 3 . Female subject childbearing potential : Has positive urine pregnancy test screening . Is willing use reliable method barrier contraception study . Using oral contraceptive birth control method . Is breastfeed . 4 . Inability adhere protocol . 5 . Use medication ( 2 week prior study ) occasional use acetaminophen . 6 . Female subject use contraceptive contain drospirenone . 7 . Subjects currently smoke . 8 . Subjects hypertension heart disease require medical treatment . 9 . Any condition possibly affect drug absorption ( e.g. , gastro intestinal disorder ) . 10 . Patients may exclude study reason , investigator 's discretion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>HCV</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>boceprevir</keyword>
	<keyword>hypertension</keyword>
	<keyword>amlodipine</keyword>
	<keyword>diltiazem</keyword>
</DOC>